World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2026

D-Index & Metrics

Best Scientists

D-Index
206
Citations
176145
World Ranking
234
National Ranking
156

Medicine

D-Index
213
Citations
185468
World Ranking
118
National Ranking
80

Research.com Recognitions

  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award

Overview

William J. Sandborn is affiliated with the University of California, San Diego in the United States. The primary fields of study in their research include Medicine and Biochemistry, Genetics and Molecular Biology, with specific focus on Genetics, Epidemiology, Surgery, Immunology, and Oncology as subfields.

Their research topics predominantly cover Inflammatory Bowel Disease, Microscopic Colitis, and Eosinophilic Esophagitis, as well as studies related to Helicobacter pylori gastroenterology, Immunodeficiency and Autoimmune Disorders, Autoimmune and Inflammatory Disorders, and Biosimilars and Bioanalytical Methods.

Frequent publication venues for their work include Gastroenterology, Journal of Crohn's and Colitis, Clinical Gastroenterology and Hepatology, The American Journal of Gastroenterology, and Inflammatory Bowel Diseases.

Notable recent papers authored or co-authored by William J. Sandborn are:

  • STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD, 2021, Gastroenterology
  • Global chemical effects of the microbiome include new bile-acid conjugations, 2020, Nature
  • Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials, 2022, The Lancet
  • Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis, 2021, New England Journal of Medicine
  • Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial, 2021, The Lancet

Frequent co-authors working with William J. Sandborn include:

  • Silvio Danese
  • Brian G. Feagan
  • Geert D'Haens
  • Bruce E. Sands
  • Laurent Peyrin-Biroulet

William J. Sandborn's publication record reflects research that intersects clinical gastroenterology and molecular biology, with a focus on therapeutic developments for inflammatory bowel conditions and related autoimmune disorders.

Best Publications

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    Jean Frédéric Colombel;William J. Sandborn;Walter Reinisch;Gerassimos J. Mantzaris

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

    Jean–Frédéric Colombel;William J. Sandborn;Paul Rutgeerts;Robert Enns

  • Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    William J. Sandborn;Brian G. Feagan;Paul Rutgeerts;Stephen Hanauer

  • Crohn's disease

    Daniel C Baumgart;William J Sandborn

  • Inflammatory bowel disease: clinical aspects and established and evolving therapies.

    Daniel C Baumgart;William J Sandborn

  • Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

    Stephen B. Hanauer;William J. Sandborn;Paul Rutgeerts;Richard N. Fedorak

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    Dan Turner;Amanda Ricciuto;Ayanna Lewis;Ferdinando D’Amico

  • A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

    Geert D’Haens;William J. Sandborn;Brian G. Feagan;Karel Geboes

  • Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    William J. Sandborn;Chinyu Su;Bruce E. Sands;Geert R. D’Haens

  • Certolizumab pegol for the treatment of Crohn’s disease:

    William J. Sandborn;Brian G. Feagan;Simeon Stoinov;Pieter J. Honiball

  • The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

    William A. Faubion;Edward V. Loftus;William S. Harmsen;Alan R. Zinsmeister

  • A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

    Christoph Gasche;Jurgen Scholmerich;Jorn Brynskov;Geert D'Haens

  • Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    William J. Sandborn;Gert van Assche;Walter Reinisch;Jean–Frederic Colombel

  • Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

    William J. Sandborn;Stephen B. Hanauer;Seymour Katz;Michael Safdi

  • Maintenance Therapy with Certolizumab Pegol for Crohn's Disease

    Stefan Schreiber;Mani Khaliq-Kareemi;Ian C. Lawrance;Ole Østergaard Thomsen

  • Adalimumab for Maintenance Treatment of Crohn's Disease: Results of the CLASSIC II Trial

    William J Sandborn;Stephen B Hanauer;Paul J Rutgeerts;Richard N Fedorak

  • Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

    William J. Sandborn;Paul Rutgeerts;Robert Enns;Stephen B. Hanauer

Frequent Co-Authors

Brian G. Feagan
Brian G. Feagan University of Western Ontario
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Edward V. Loftus
Edward V. Loftus Mayo Clinic
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Siddharth Singh
Siddharth Singh University of California, San Diego
Walter Reinisch
Walter Reinisch Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or flexible pathways, there is a growing range of online degrees related to healthcare and the medical field. Choosing an online program can make higher education more affordable and accessible, especially for working adults or career changers.

Registered nurses looking to advance quickly may consider some of the cheapest online BSN to DNP programs, allowing them to obtain a Doctor of Nursing Practice degree with lower costs and greater flexibility. Pharmacists, meanwhile, might explore earning their 3 year online PharmD, streamlining their path to a doctoral degree without relocating or pausing their careers.

Not all healthcare roles require a doctorate or direct patient care. For instance, those drawn to the business and technology side of healthcare can look into online schools for health information management, a field critical for data integrity and patient record safety. Similarly, students seeking quick entry into healthcare jobs may examine how much does it cost to become a medical coder—a vital, in-demand profession supporting hospitals and clinics from behind the scenes.

Best Scientists Citing William J. Sandborn

Trending Scientists

Recently Published Articles